Seroreactivity to human papillomavirus type 16 (HPV-16) virus-like particles (VLPs) in men attending clinics for sexually transmitted diseases (STDs) in Denmark (n Å 219) and Greenland (n Å 88) was compared with seroreactivity in women attending the same clinics and was furthermore related to epidemiologic variables and concurrent HPV DNA detection. Risk factors for male seropositivity in Denmark were lifetime number of sex partners, a history of STDs, and sexual preference and in Greenland were ever having had syphilis and years at school. Although men reported significantly more sex partners, the mean seroreactivity was significantly lower in men than in women: 0.50 and 0.75, respectively, in Denmark and 0.53 and 0.86 in Greenland (P Å .0001). Male seropositivity was not correlated with concurrent HPV DNA detection, but only 15 Danish and 6 Greenlandic men had HPV-16 DNA. Presence of HPV-16 VLP antibodies appears to be a biomarker for exposure to genital HPVs in men but is less sensitive than in women.
In the epidemiology of cervical neoplasia, the concept of ample, that most HPV infections in women are transient [11] and relatively harmless compared to a smaller number of persis-''the male factor'' refers to characteristics of the male sex partner, which have consistently been shown to contribute to tent infections, which have the potential of inducing oncogenic progression in the cervical epithelium [12] . In men, the natural the risk of the disease in the female consort [1 -5] . Male highrisk sexual behavior, such as having multiple sex partners, history of genital HPV infection is even less well-studied, and the frequency of transient and persistent infections is not visiting prostitutes, and a history of sexually transmitted diseases (STDs), increases cervical cancer risk in the female conknown. Recently, serologic assays using correctly assembled HPVsort.
Cervical infection with certain human papillomaviruses 16 virion proteins as antigen have been developed [13, 14] . By these assays, serum IgG virion antibodies are measured by (HPVs), especially HPV-16, is accepted to be the major risk factor in cervical carcinogenesis [6 -8] . HPV DNA detection ELISA. Seroreactivity to these HPV-16 virus-like particles (VLPs) has been found higher in women with neoplasia of the rates in women have been shown to increase with increasing number of sex partners [9, 10] , underlining the importance of uterine cervix than in healthy women in case-control studies from Colombia, Spain, and Sweden [15, 16] and to correlate sexual activity in HPV transmission. In a recent study from directly with the risk for cervical cancer when comparing areas Spain, risk of cervical cancer was 5-fold higher in women with different incidence [15, 17] . Furthermore, significantly whose regular partner had penile HPV DNA [4] .
higher seroreactivity has been found in women with persistent Although the natural history of HPV infection is not well genital HPV infection [18] . understood, some assumptions are generally accepted, for exCorresponding studies of seroreactivity to HPV-16 VLPs in men and its relationship to epidemiologic variables and to concurrent detection of genital HPV infection have not been 877 JID 1997; 176 (October) Seroreactivity to HPV-16 VLPs in Men
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No specific age-matching was performed, but the age distri- 16 DNA positivity tended to be higher in the women than in an unconditional multiple logistic regression analysis computing men from Denmark, whereas in the Greenlandic populations, odds ratios (ORs) with 95% confidence intervals (CIs) to adjust HPV-16 DNA prevalence was similar in men and women. cantly lower than in women from the same area. When the 
cut point was used, 42 DM (19%) and 23 GM (26%)
Risk of seropositivity increased with increasing number of sex partners in both populations (table 4; figure 2 ). In Denmark, were seropositive. With the same cut point, 50% of the Danish women and 66% of the Greenlandic women were seropositive.
ORs for seropositivity in men with 20 -39 partners and §40 partners were, respectively, 3.1 (95% CI: 1.2 -8.1) and 4.9 Risk factors for seropositivity. Risk of seropositivity was significantly higher in the oldest men than in the youngest men (95% CI: 2.0 -11.9) times higher than in men with 1 -19 partners. Correspondingly, in Greenland, risk was higher in men in both areas, but the increase in risk appeared at different ages (table 4) . In GM aged 25 -29 years and §30 years, risks of reporting §40 partners (OR Å 3.3; 95% CI: 1.0 -11.0) than in men with fewer partners. After adjustment, the association seropositivity were, respectively, 6.5 times (95% CI: 1.3 -33.5) and 4.7 times higher (95% CI: 0.9 -23.3) than in men aged with lifetime partners remained significant only in DM. Age at first sexual intercourse was not related to risk of seropositiv-18 -24 years. In DM, risk of seropositivity was not significantly different in the age groups 25 -29 years and 30 -34 years (OR ity in any of the populations. In both areas, an association with a self-reported history Å 1.2 and 0.6, respectively) compared with the age group 18 -24 years but increased 2.8 times (95% CI: 1.0 -7.5) in men of any STDs (including gonorrhoea, Chlamydia infection, genital warts, genital herpes, and syphilis) was found (table aged §35 years. In both populations, the association with age was no longer significant after adjustment, although the ten-4). Risk of seropositivity was 3.5 times higher in DM with a history of STDs than in men without, and this association dency remained. tivity in the DM. Among variables that were not related to 1.1 -6.3). Only 6 of the GM had never had any STD, and seropositivity in any of the populations were number none of them were seropositive. A self-reported history of of partners in the last year, visits to prostitutes, circumsyphilis was associated with a 4.5 times higher risk of serocision, frequency of genital washes, and smoking (data not positivity in GM, which remained almost unchanged after shown). adjustment (OR Å 4.6; 95% CI: 1.2 -17.6). Also, the 6 DM Finally, we repeated the risk factor analysis and used other cut points to define seropositivity (0.55, 0.75, and 0.85). Whatwho had a history of syphilis were more likely to be seroposi- ever the cut point used, the same pattern of risk factors was In figure 3 , the relationship between lifetime partners and seropositivity for 4 subgroups of HPV DNA status is shown found (data not shown).
Association between seropositivity and genital HPV DNA for DM: HPV-16 DNA -positive, HPV DNA -positive for other types than 16, HPV-16 DNA -negative, and HPV DNAdetection. In DM, frequency of seropositivity was not significantly different between men who were positive for any negative. Although numbers were small, seropositivity did not seem to be associated with number of partners in HPV-16 -HPV DNA (16/102, 16%), positive for HPV-16 DNA (3/15, 20%), or HPV DNA -negative (24/107, 22%) (data not shown).
DNA positive men, in contrast to the tendencies found for the other 3 subgroups. In GM, ELISA positivity tended to be higher among HPV DNA -negative (15/46, 33%) than among HPV DNA -positive men (8/42, 19%) (P Å .1), and none of the 6 HPV-16 DNADiscussion positive Greenlanders was seropositive.
As seropositivity may have different implications in HPV This is the first study to evaluate antibodies against HPV-16 VLPs as a marker of genital HPV-16 infection in men. DNA -positive and HPV DNA -negative men, the multiple regression analysis was repeated after stratification for genital Overall, the results support the validity of anti-VLP antibodies as a marker of genital HPV-16 infection in men. Assuming HPV DNA status as defined by general primer PCR (any HPV), as shown for the DM in table 5. After allowing for potential that, overall, men and women attending the same STD clinics have similar rates of exposure to genital HPV, the results sugconfounders, Danish HPV DNA -negative men with a history of any STDs were 7.8 (95% CI: 1.8 -33.3) times more likely gest that VLP seropositivity is a less sensitive marker of genital HPV infection in men than it is in women. As the men had to be seropositive than were men without a history of STDs. Also, bisexual men were 7.3 times (95% CI: 1.7 -31.5) more more sex partners than did the women, it is not likely that the potential risk of exposure to HPV in men was lower than in likely to be seropositive than were heterosexual men. Lifetime number of partners was an important variable in the univariate the women. In VLP-based studies of seroreactivity in women, the cutoff analysis and remained marginally significant after adjustment. Whereas age was not related to risk of seropositivity in the points for seropositivity have been chosen in various ways. For example, in case-control studies of cervical cancer and HPV DNA -negative DM, risk of seropositivity was 6.1 times higher in the oldest HPV DNA -positive DM ( §35 years) precancerous lesions, the respective sensitivities and specificities of the assay at different cut points were compared using than in the youngest men (18 -24 years). After adjustment, the association was no longer significant (OR Å 4.2; 95% CI: 0.7 -receiver operating characteristics curves [15] . In other studies, mean OD in serum from women who were unlikely to be 25.8). HPV DNA -positive men with §40 sex partners had a 5.5 times higher risk of seropositivity (95% CI: 1.0 -29.4), and HPV-16 -infected, plus 2 -2.5 standard deviations, defined the highest seronegative value [14, 18] . In this study, however, also men with a history of STDs and bisexual men had an increased risk of seropositivity, but these associations were not there is neither a disease that would define a case status nor persons who are unlikely to be exposed to the virus that could significant.
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07-29-97 14:29:43 jinfal UC: J Infect constitute a control group. Therefore, we cannot evaluate the Increasing seropositivity with lifetime number of partners and, to a lesser degree, with age were found in both groups of sensitivity or specificity of the assay at different cut points. However, using other cut points than 0.65 in the multiple logismen examined, confirming a similar trend found in women in the study [17] . Since the participating men were, on average, tic regression analysis did not change the overall conclusions of the study.
older and had more partners, a higher level of seropositivity in men than in women might have been expected. However, pared with GM. This is in line with our previous finding in women in the study [17] . Part of the explanation for this differin both Denmark and Greenland, men were significantly less likely to be seropositive, independent of the cut point used to ence may the younger age at first coitus and perhaps also a higher number of partners in the first sexually active years in define seropositivity. Thus, the lower seropositivity found in men could not be explained by difference in key demographic
Greenland, but we have no data to evaluate this hypothesis. In addition, there may also be a higher background prevalence of variables. Therefore, biologic differences between the sexes are likely to account for the differences in seroprevalence.
HPV-16 in Greenland. Consistent with this idea, more GM than DM with relatively few lifetime partners were seropositive. For Possible explanations include male infections tending to be more transient, as has been suggested in a recent study of HPV example, among the GM who reported 1 -9 sex partners, 29% (2/7) were ELISA-positive, whereas this applied to only 4% DNA in men [4] . Also, infection of the male genitalia, with predominantly cornified epithelial surfaces, may be less likely (2/49) of the corresponding DM (P Å .02). In addition, the high prevalences of other STDs in Greenland may contribute to induce a detectable humoral immune response than is infection of the female genital tract, which has primarily mucosal to the early acquisition of HPV-16 infection. Seropositivity did not correlate with HPV DNA detection, surfaces. Consistent with this finding, recent studies of patients with genital warts found significantly lower seroreactivity to and this is in line with our findings in women in the study [17] . In addition, in a study of reactivity to HPV-16 VLPs in HPV-6 VLPs [23] and to HPV-6 capsids [24] in men than in women.
women with incident high-grade dysplasia [26] , there was a low correlation between seropositivity and HPV DNA detection, Despite substantial differences regarding various variables related to sexual life in the male populations, we found no especially in control women. A possible explanation of this lack of correlation may be that -in both sexes -the serologic clear geographic difference in the overall seropositivity rate. However, high-level seroreactivity (OD readings §1.0) tended assay measures both past (now cleared) and present infection. Wideroff et al. [27] have recently reported that seropositivity to be more common in GM, suggesting a higher level of exposure. Several similarities in the pattern of risk factors for seroagainst HPV-16 VLPs increased markedly with lifetime number of partners in HPV-16 DNA -negative women, whereas no positivity were found in both populations, especially regarding variables related to sexual activity. In DM, a history of any influence was found in HPV-16 DNA -positive women. Because of the limited number of HPV-16 DNA -positive men STD was a strong predictor of seropositivity. In GM, who were more sexually active and among whom most (93%) had had in this study (15 DM and 6 GM), we cannot study predictors of seropositivity in this group in detail. However, as illustrated some STDs, ever having syphilis may be the discriminating factor for higher-risk sexual behavior. Likewise, the high seroin figure 3 for DM, a similar pattern was found in this study. There was no association between lifetime partners and serorereactivity in bisexual DM may be explained by these men having more high-risk partners. In line with this hypothesis, activity in HPV-16 DNA -positive men but a clear increasing trend in men HPV DNA -positive for other types than 16, bisexual men reported more STDs, especially syphilis (11% vs. 1%), than did heterosexual men (data not shown). Years at HPV-16 DNA -negative, and HPV DNA -negative. Presence of DNA from other HPV types than HPV-16 may school, which was another important risk factor in GM, may also be a proxy variable for higher-risk behavior.
be interpreted as a proxy measure for potential exposure to HPV-16. While the influence of lifetime partners on seroposiThe association between seroreactivity and other STDs could be interpreted as a surrogate measure for exposure to HPVtivity showed the same trends in the HPV DNA -negative and the HPV DNA -positive (any type) DM (table 5) , we find it 16 but could additionally suggest that other genital infections somehow interact with HPV-16 infection, perhaps by facilitatnotable that the association between seropositivity and a selfreported history of STDs and sexual preference was markedly ing the presentation of the virus to the immune system. For example, this could occur via a gonococcal urethritis or herpetic stronger in HPV DNA -negative men. Thus, as has been found for women [27] , seropositivity in HPV DNA -negative men ulcerations, as has been found for HIV-1 and genital ulcers [25] . Also, concurrent infection with other pathogens may may be a measure of prior exposure to the virus. The implications of the stronger association between age and seropositivity somehow increase the possibility that a given HPV exposure will lead to infection or to persistence of infection.
in HPV DNA -positive than in HPV DNA -negative DM is uncertain, and possible conclusions must await studies large The strong association between seroreactivity and variables related to sexual life found in this study suggests that most HPVenough to allow analysis of the association in HPV-16 DNApositive men separately. 16 infections are in the genital area. It is possible that the association with lifetime number of sex partners would have been even stronger if more men with relatively few partners were included
